3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with Alcoholic Fatty Liver in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J | 1 |
1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and Alcoholic Fatty Liver
Article | Year |
---|---|
Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Depressants; Cyclooxygenase 2; Endotoxins; Ethanol; Fatty Liver, Alcoholic; Fibrosis; Lipid Peroxidation; Liver; Male; NF-kappa B; Oxazoles; Pyridines; Rats; Rats, Wistar; Receptors, Thromboxane; RNA, Messenger; Thromboxane-A Synthase; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2013 |